Cargando…

Potential Risks and Benefits of Multiple Sclerosis Immune Therapies in the COVID-19 Era: Clinical and Immunological Perspectives

Coronavirus SARS-CoV2 has emerged as one of the greatest infectious disease health challenges in a century. Patients with multiple sclerosis (MS) have a particular vulnerability to infections through their use of immunosuppressive disease-modifying therapies (DMTs). Specific DMTs pose particular ris...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhise, Vikram, Dhib-Jalbut, Suhayl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2021
Materias:	Current Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7853164/ https://www.ncbi.nlm.nih.gov/pubmed/33533012 http://dx.doi.org/10.1007/s13311-021-01008-7

Ejemplares similares

Multiple sclerosis: Possible immunological mechanisms()
por: McFarland, Henry F., et al.
Publicado: (1989)

Interaction of the Gut Microbiome and Immunity in Multiple Sclerosis: Impact of Diet and Immune Therapy
por: Yadav, Sudhir Kumar, et al.
Publicado: (2023)

Effect of switching glatiramer acetate formulation from 20 mg daily to 40 mg three times weekly on immune function in multiple sclerosis
por: Ito, Kouichi, et al.
Publicado: (2021)

Mechanism of measles virus failure to activate NF-κB in neuronal cells
por: Fang, Yu -Yan, et al.
Publicado: (2001)

Interleukin-1β decreases HLA class II expression on a glioblastoma multiforme cell line
por: Cowan, Elliot P., et al.
Publicado: (1991)

Early Treatment with Anti-VLA-4 mAb Can Prevent the Infiltration and/or Development of Pathogenic CD11b(+)CD4(+) T Cells in the CNS during Progressive EAE
por: Mindur, John E., et al.
Publicado: (2014)

Dimethyl Fumarate Suppresses Demyelination and Axonal Loss through Reduction in Pro-Inflammatory Macrophage-Induced Reactive Astrocytes and Complement C3 Deposition
por: Yadav, Sudhir K., et al.
Publicado: (2021)

A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
por: Frisch, Esther S., et al.
Publicado: (2021)

Fecal Lcn-2 level is a sensitive biological indicator for gut dysbiosis and intestinal inflammation in multiple sclerosis
por: Yadav, Sudhir K., et al.
Publicado: (2022)

Monthly triple-dose gadolinium administration: potential associations with leukopenia, hypophosphatemia, and bone marrow T1 hyperintensity
por: Chen, Daniel, et al.
Publicado: (2022)

Adult human glial cells can present target antigens to HLA-restricted cytotoxic T-cells
por: Dhib-Jalbut, Suhayl, et al.
Publicado: (1990)

Immunological role of sulfatide in the pathogenesis of multiple sclerosis
por: Hamatani, Mio, et al.
Publicado: (2023)

Perspectives on neuroreparative therapies for treating multiple sclerosis
por: Xiao, Junhua
Publicado: (2015)

Surface Layer Protein A Expressed in Clostridioides difficile DJNS06-36 Possesses an Encephalitogenic Mimotope of Myelin Basic Protein
por: Mindur, John E., et al.
Publicado: (2020)

Alpha-synuclein Immunization Strategies for Synucleinopathies in Clinical Studies: A Biological Perspective
por: Knecht, Luisa, et al.
Publicado: (2022)

Maskne: A New Acne Variant in Covid-19 Era
por: Rathi, Sanjay K., et al.
Publicado: (2022)

Pediatric multiple sclerosis
por: Patel, Yashma, et al.
Publicado: (2009)

Tremor in Multiple Sclerosis—An Overview and Future Perspectives
por: Makhoul, Karim, et al.
Publicado: (2020)

Immunotherapies for Aging-Related Neurodegenerative Diseases—Emerging Perspectives and New Targets
por: Kwon, Somin, et al.
Publicado: (2020)

Induction Therapy for Patients with Multiple Sclerosis: Why? When? How?
por: Edan, Gilles, et al.
Publicado: (2013)

Current perspectives for SARS-CoV-2 vaccination efficacy improvement in patients with active treatment against cancer
por: Barrière, Jérôme, et al.
Publicado: (2021)

Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
por: Di Cosimo, Serena, et al.
Publicado: (2020)

The role of cord blood banks in the cell therapy era: future perspectives
por: Lee, Young-Ho
Publicado: (2017)

Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients
por: Mansi, Laura, et al.
Publicado: (2021)

Update on Intravenous Immunoglobulin in Neurology: Modulating Neuro-autoimmunity, Evolving Factors on Efficacy and Dosing and Challenges on Stopping Chronic IVIg Therapy
por: Dalakas, Marinos C.
Publicado: (2021)

Multiple Sclerosis Disease-Modifying Therapy and the COVID-19 Pandemic: Implications on the Risk of Infection and Future Vaccination
por: Zheng, Crystal, et al.
Publicado: (2020)

Role of Multiple Infections on Immunological Variation in Wild Populations
por: Tate, Ann T.
Publicado: (2019)

Potential Immunologic and Integrative Methods to Enhance Vaccine Safety
por: Dattner, Alan M.
Publicado: (2022)

Age-old wisdom concerning cell-based therapies with added knowledge in the stem cell era: our perspectives
por: Preethy, Senthilkumar, et al.
Publicado: (2013)

Drug repurposing for neuroregeneration in multiple sclerosis
por: Küry, Patrick, et al.
Publicado: (2018)

Targeting metabolism to treat multiple sclerosis
por: Bhargava, Pavan
Publicado: (2020)

Multiple sclerosis drug repurposing for neuroregeneration
por: Göttle, Peter, et al.
Publicado: (2023)

Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
por: Macchi, Beatrice, et al.
Publicado: (2016)

A historical perspective on ACE2 in the COVID-19 era
por: Bhalla, Vivek, et al.
Publicado: (2020)

Self-experimentation in the COVID Era: Is it morally justifiable? – A perspective
por: Sinha, Ankit, et al.
Publicado: (2022)

Testosterone replacement therapy in the era of telemedicine
por: Dubin, Justin M., et al.
Publicado: (2021)

Mesenchymal stem cells require the peripheral immune system for immunomodulating effects in animal models of multiple sclerosis
por: Salinas Tejedor, Laura, et al.
Publicado: (2016)

Soluble interleukin 23 receptor gene therapy with adeno-associated vectors for the treatment of multiple sclerosis
por: Edo, Ángel, et al.
Publicado: (2017)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Evolving Ideas on the Origin and Evolution of Flowers: New Perspectives in the Genomic Era
por: Chanderbali, Andre S., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fep2o4jnsad9ot6nh0k36rp0fh